Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
We received an updated WNV package insert; please note the manufacturer and license number has been ...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...